GEN Edge - Latest

Latest

Artificial Intelligence

Inside VC: Samir Kaul of Khosla Ventures on Evaluating and Managing Risk in 2023

Bayer

Top 10 Ambition: Bayer Aims for $10 Billion in Cancer Drug Sales by 2030

Gene Therapy

StockWatch: Seven Analysts Cut Price Target for Taysha on FDA Advice, Job Cuts

CRISPR

Sherlock Biosciences Acquires Sense Biodetection to Commercialize Disposable CRISPR-Based Diagnostics

Financing

EY Eyes Comeback for Biopharma M&A

Coronavirus

Developing the Next Generation of SARS-CoV-2 Vaccines

Artificial Intelligence

Zero-Shot Moonshot: Absci Uses AI Platform to Create and Validate de novo Antibodies

Leukemia

StockWatch: Patient Death Rattles Magenta Therapeutics, Analysts

Cell Therapy

Hit Pause: The Read-Across to Graphite Bio’s CEDAR Sickle Cell Trial Suspension

Gene Therapy

Rough Passage: Gene Therapy Developer Hunkers Down after Job, Pipeline Cuts

Kinases

Incyte Moves to Broaden Revenue beyond Jakafi

Autoimmune Disorders

Sanofi Extends Deal with CytoReason to License IBD Disease Modeling

Infectious Diseases

StockWatch: Moderna’s Positive Phase III RSV Vaccine Data Wows Analysts

Drug Discovery

NextPoint Therapeutics Reports $80 Million Series B for Novel Immuno-Oncology Programs

Genome Editing

A16z’s Vijay Pande: Why Gene Editing Will Soon Be “Off to the Races”

Artificial Intelligence

Engineering Biology: a16z’s Vijay Pande Discusses Shift from Bespoke Drugs

CRISPR-Cas9

Arbor and Vertex to Advance Reverse Transcriptase Genetic Medicines

Financing

StockWatch: Shares Double for Targets of 3 Buyout Deals Announced at JPM

GEN Edge

Reporter’s Notebook: On Day 2 of J.P. Morgan, Start-Ups Soliciting Cash and VCs Eschewing High Risk

GEN Edge

Reporter’s Notebook: Day 2 at the J.P. Morgan Healthcare Conference

Artificial Intelligence

Biotech Leaders Discuss Therapeutic Breakthroughs at the WuXi AppTec Global Forum

Biomarker Discovery

Alto Neuroscience Announces Positive Phase II Results Supporting Precision Psychiatry Platform

GEN Edge

Reporter’s Notebook: Opening Day at the J.P. Morgan Healthcare Conference

Whole-Genome Analysis

At JPM, Illumina Announces African-American Sequencing Collaboration

Cancer

StockWatch: Investors Embrace Geron’s Comeback Story

Drug Discovery

PhoreMost Achieves Target Discovery Milestone with Boehringer Ingelheim

Cell Therapy

Lineage Cell Therapeutics Makes Medicines Based on Transplanting Differentiated Cells

Oncologics

Olema Plans Pivotal Trial for Two-Prong Breast Cancer Treatment

Eye Disorders

Opus Genetics Acquires Two Gene Therapy Candidates for Inherited Retinal Diseases

Bioprocessing

From Smudge to Sequence: Quantum-Si Commercializes the First Single-Molecule Protein NGS Platform